Newest first. 5.2k questions across 107 tags.
What I am working with: WXT · JEEP · Finland. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
What I am working with: retatrutide · two weeks · 37 °C. I am trying to build something sustainable rather than something thorough that I will abandon. I have already…
Stated plainly: 5 mg · 1 mL · bacteriostatic water · tirzepatide. I am trying to build something sustainable rather than something thorough that I will abandon. I…
Setup, so nobody has to ask: Janoshik · 99.1%. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded…
Stated plainly: Wuhan · Spain. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I do not…
Details up front: KP · Shanghai ERP Biotechnology. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Numbers first: eGFR · retatrutide. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Numbers first: 2 mg · 2.5 mg/mL. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is what…
Numbers first: SURMOUNT-3 · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
What I have: a stablecoin transfer · Singapore. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum…
What I have: KP · FGP · Germany. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason than a…
Numbers first: a GLP-1 receptor agonist · minus 20 °C · seven days. This is a planning question. I know what my options are; I do not know how to weigh them. What I…
Numbers first: a GLP-1 receptor agonist · semaglutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Details up front: 97.6% · dulaglutide. This should be a straightforward calculation and I keep getting two different answers. The numbers are arbitrary; the method is…
The case in front of me: semaglutide · 8 mg. Please show the division. I want to check my own against yours. I would like the general form as well as the specific…
The case in front of me: 1 mg/mL · oral semaglutide. I would like the axes of comparison first and the recommendation second. I have tried the first option and it…
The case in front of me: semaglutide · four weeks · 25 °C. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted…
Concretely: a U-40 insulin syringe · 8 mg · 6.67 mg/mL. Please show the division. I want to check my own against yours. I would like the general form as well as the…
I am comparing three suppliers on documentation rather than on price. I would like to know the limits of what can be inferred from this. What I am trying to avoid is…
Concretely: SURPASS-3 · injection-site erythema · 20 mg. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading…
Conditions: STEP 2 · oral semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
The specifics, since they change the answer: AST · ALT · mazdutide. The comparison I want does not seem to exist anywhere in a form I can evaluate. I have read the…
The particulars: reflux · seven · a GLP-1 receptor agonist. I want a method I can write down and repeat, not a rule of thumb. I would rather over-engineer this than…
The specifics, since they change the answer: tirzepatide · 6.67 mg/mL. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan…